BioCatalystWatch
ONCYWorkspace / ONCY / OverviewCompany library
ONCOLYTICS BIOTECH INC logo

ONCOLYTICS BIOTECH INC

ONCOLYTICS BIOTECH INC (ONCY)

Website

Price
Market cap
Next catalystDec 12, 2026pelareorep + bortezomib + dexamethasone + pembrolizumab — multiple myeloma · Phase 1/2 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

pelareorep

PreINDP1P2P3FilingApproved
Upcoming / outlook

pelareorep

PreINDP1P2P3FilingApproved
Upcoming / outlook

pelareorep

PreINDP1P2P3FilingApproved
Upcoming / outlook

pelareorep

Upcoming / outlook

pelareoreppelareorep + bortezomib + dexamethasone + pembrolizumab — multiple myeloma

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

pelareorep

PreINDP1P2P3FilingApproved
Upcoming / outlook

pelareoreppelareorep + bortezomib + dexamethasone + pembrolizumab — multiple myeloma

PreINDP1P2P3FilingApproved
Upcoming / outlook

pelareorep

PreINDP1P2P3FilingApproved
Upcoming / outlook

pelareorep

Upcoming / outlook

pelareorep

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

pelareorep

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ONCY PR & News

PR & News

ONCY SEC archive